Coudeville, L.; Konate, E.; Simon, T.; de Lamballerie, X.; Patterson, S.; El Guerche-Séblain, C.; Launay, O., on behalf of AP-PH COVIBOOST Vaccine Trial Group.
Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling. Vaccines 2024, 12, 1079.
https://doi.org/10.3390/vaccines12091079
AMA Style
Coudeville L, Konate E, Simon T, de Lamballerie X, Patterson S, El Guerche-Séblain C, Launay O on behalf of AP-PH COVIBOOST Vaccine Trial Group.
Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling. Vaccines. 2024; 12(9):1079.
https://doi.org/10.3390/vaccines12091079
Chicago/Turabian Style
Coudeville, Laurent, Eleine Konate, Tabassome Simon, Xavier de Lamballerie, Scott Patterson, Clotilde El Guerche-Séblain, and Odile Launay on behalf of AP-PH COVIBOOST Vaccine Trial Group.
2024. "Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling" Vaccines 12, no. 9: 1079.
https://doi.org/10.3390/vaccines12091079
APA Style
Coudeville, L., Konate, E., Simon, T., de Lamballerie, X., Patterson, S., El Guerche-Séblain, C., & Launay, O., on behalf of AP-PH COVIBOOST Vaccine Trial Group.
(2024). Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling. Vaccines, 12(9), 1079.
https://doi.org/10.3390/vaccines12091079